PANTDOSE-LS CAP 

Product Description

PANTDOSE-LS contains Pantoprazole 40 mg and levosulpride 75 mg, a gastrointestinal combination that pairs a proton pump inhibitor with a prokinetic agent. Pantoprazole decreases stomach acid secretion, while levosulpiride enhances upper digestive tract motility and supports gastric emptying. The formulation is intended for conditions where acid-related symptoms occur alongside disturbed gastrointestinal movement.  

Indications

• Gastro-oesophageal reflux disease
• Heartburn and acid regurgitation
• Functional dyspepsia
• Delayed gastric emptying
• Post-meal heaviness
• Abdominal bloating

Key Benefits

• Suppresses excessive acid secretion
• Relieves reflux-related burning
• Promotes efficient gastric emptying
• Supports coordinated gastrointestinal movement
• Helps reduce post-meal discomfort
• May improve digestive symptom control
• Offers dual-action gastrointestinal support